Aleksandra Lopez Krol, Luana Silva, Daniele C. Nascimento, Sophie M. Oberwalder, Hitikk Chawla, Gabriel Alberto Barbosa de Carvalho, Fatima Boukhallouk, Monica Romero, Anne Hausen, Matthias M. Gaida, Luciana Berod, José Carlos Alves-Filho, Tim Sparwasser
{"title":"Inducible cAMP Early Repressor Limits Glycolytic Programming in Regulatory T Cells and Supports Control of Inflammatory Colitis","authors":"Aleksandra Lopez Krol, Luana Silva, Daniele C. Nascimento, Sophie M. Oberwalder, Hitikk Chawla, Gabriel Alberto Barbosa de Carvalho, Fatima Boukhallouk, Monica Romero, Anne Hausen, Matthias M. Gaida, Luciana Berod, José Carlos Alves-Filho, Tim Sparwasser","doi":"10.1002/eji.70297","DOIUrl":null,"url":null,"abstract":"<p>Regulatory T cells (Tregs) are essential for immune tolerance, with cAMP metabolism central to their suppressive function. Inducible cAMP early repressor (ICER) is a negative regulator of cAMP signalling. However, its role in Treg biology is not fully understood. Here we generated Foxp3-specific ICER knockout mice to assess ICER's function in Tregs. We found that ICER deficiency does not impair Treg development or suppression of effector T cell proliferation under homeostatic conditions. However, ICER-deficient Tregs display enhanced Foxp3 stability, increased glycolysis and proliferation but exhibit impaired suppression of IFN-γ production by effector T cells. In a dextran sodium sulphate-induced colitis model, loss of ICER in Tregs led to aggravated intestinal inflammation and tissue damage, without, however, a marked effect on gross disease parameters. These results identify ICER as a context-dependent modulator of Treg metabolism and inflammatory cytokine control, highlighting its potential role in regulating immune responses during inflammation.</p>","PeriodicalId":165,"journal":{"name":"European Journal of Immunology","volume":"56 10","pages":""},"PeriodicalIF":4.1000,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.70297","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Immunology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/eji.70297","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Regulatory T cells (Tregs) are essential for immune tolerance, with cAMP metabolism central to their suppressive function. Inducible cAMP early repressor (ICER) is a negative regulator of cAMP signalling. However, its role in Treg biology is not fully understood. Here we generated Foxp3-specific ICER knockout mice to assess ICER's function in Tregs. We found that ICER deficiency does not impair Treg development or suppression of effector T cell proliferation under homeostatic conditions. However, ICER-deficient Tregs display enhanced Foxp3 stability, increased glycolysis and proliferation but exhibit impaired suppression of IFN-γ production by effector T cells. In a dextran sodium sulphate-induced colitis model, loss of ICER in Tregs led to aggravated intestinal inflammation and tissue damage, without, however, a marked effect on gross disease parameters. These results identify ICER as a context-dependent modulator of Treg metabolism and inflammatory cytokine control, highlighting its potential role in regulating immune responses during inflammation.
调节性T细胞(Tregs)对免疫耐受至关重要,cAMP代谢是其抑制功能的核心。诱导型cAMP早期抑制因子(Inducible cAMP early repressor, ICER)是cAMP信号的负调控因子。然而,其在Treg生物学中的作用尚不完全清楚。在这里,我们产生了foxp3特异性ICER敲除小鼠来评估ICER在Tregs中的功能。我们发现,在稳态条件下,ICER缺乏不会损害Treg的发育或抑制效应T细胞的增殖。然而,icer缺陷Tregs表现出Foxp3稳定性增强,糖酵解和增殖增加,但效应T细胞对IFN-γ产生的抑制受损。在葡聚糖硫酸钠诱导的结肠炎模型中,Tregs中ICER的缺失导致肠道炎症和组织损伤加重,但对总体疾病参数没有明显影响。这些结果表明,ICER是Treg代谢和炎症细胞因子控制的环境依赖性调节剂,强调了其在炎症期间调节免疫反应的潜在作用。
期刊介绍:
The European Journal of Immunology (EJI) is an official journal of EFIS. Established in 1971, EJI continues to serve the needs of the global immunology community covering basic, translational and clinical research, ranging from adaptive and innate immunity through to vaccines and immunotherapy, cancer, autoimmunity, allergy and more. Mechanistic insights and thought-provoking immunological findings are of interest, as are studies using the latest omics technologies. We offer fast track review for competitive situations, including recently scooped papers, format free submission, transparent and fair peer review and more as detailed in our policies.